Logo of Sorrento Therapeutics

Jaisim Shah Email Address

abcde@sorrentotherapeutics.com

Need many emails like this?Find your leads with our LinkedIn Email Finder.If you already have names, use our Email Finder by Name (available in Bulk or via API too).
Job Title

Chief Executive Officer Scilex Holding

Company
Sorrento Therapeutics

Focusing on the development of oncologic agents for the treatment for cancers

Bio

CEO, Board Director growing shareholder value at life science companies. Successful accomplishments at Bristol-Myers, Roche, PDL, Sorrento, Elevation, Semnur/Scintilla Pharmaceuticals.Over 25 year industry success in product development & commercializing therapies at Roche, BMS, PDL. Managed late stage product development for Rituxan, Pegasys, Abilify pre-launch teams, each over $2 billion sales. Have successfully led product development plans and operational teams. Broad Expertise in product development, commercialization of compounds in variety of indications: Oncology, Respiratory, Immunology, Infectious Disease, Virology, CNS, Autoimmune, Inflammation, CV, Pain. Milestones: Created and implemented successful alliances/M&A transactions - $1.2 billion collaboration PDL/BMS (Top 5 Antibody Mega Deals, BioCentury 2009)- $800 million PDL-Biogen Idec collaboration- $430 million Elevation Pharma to Sunovion (Top 10 Acquisitions of VC companies, WSJ 2012)- $200 million sale of IV Busulfex to Otsuka - $300 million multiple collaborations with Roche- Sorrento acquisition of Igdrasol/CynviloqGlobal deal-maker with proven partnering and negotiation skills, strong track record of closing licensing and strategic partnerships with cumulative deal values of >$1 billion. Held senior leadership positions at global and development stage companies, VP of Franchise Management at Bristol-Myers Squibb, Chief Business Officer at PDL and Elevation, CEO at Semnur, Board Director at Sorrento. Honored with numerous company awards, including BMS President’s Award. Expertise in M&A and Collaborations with Bristol-Myers Squibb, total transaction value of more than $1 billion, as well as a global transaction with Biogen Idec, with a total transaction value of $800 million, and multiple collaborations with Roche with transaction values of more than $350 million. Sale of Elevation to Dainippon Sumitomo for $430m.

Location
Is based in San Francisco, California, United States.

Other people working at Sorrento Therapeutics:

Yanwen FuExecutive Director, Chemical Immunotherapy and ADC R and D
Guo WenzhongChief Technology Officer, Cell Therapy
Bill FarleyBusiness Development Executive
Gunnar KaufmannChief Scientific Officer
Alexis NahamaSenior Vice President Corporate Development, Head of Pain and Inflammation BU, Head of Brazil Operations
Henry Ji***@sorrentotherapeutics.com
J. Cason******@sorrentotherapeutics.com
Troy W. GardnerGeneral Manager, Bioserv
Hui LiPresident and Chief Executive Officer
Tong ZhuExecutive Director of Chemistry
George NgChief Executive Officer and Board Director
Jeffrey SuEntitlement Project Manager at Rockport Development Inc and MS in Project Management Candidate at USC
Kevin HolzwarthSenior Scientist
S. Schaus*******@sorrentotherapeutics.com

How does this work?

Anymail finder is trusted by tens of thousands of companies to provide accurate contact information to their Sales and Business Development teams.

If you're looking to find the email of Jaisim Shah at Sorrento Therapeutics then you've come to the right place.

Wondering if it's jaisim@sorrentotherapeutics.com, jaisim.shah@sorrentotherapeutics.com, shah@sorrentotherapeutics.com, or jshah@sorrentotherapeutics.com? We have the answers for you.

Looking for somebody else’s email?

Find other Emails now